These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 6712181

  • 1. Lewis lung carcinoma lines with different metastatic behavior: response to ICRF-159.
    Zupi G, Cavallari A, Greco C, Sacchi A.
    Anticancer Res; 1984; 4(1-2):91-5. PubMed ID: 6712181
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic activity of ICRF-159 combined with surgery: effects of postsurgical treatment with cyclophosphamide in mice bearing Lewis lung carcinoma lines.
    Sava G, Zorzet S, Perissin L.
    Anticancer Res; 1985; 5(5):511-5. PubMed ID: 4062252
    [Abstract] [Full Text] [Related]

  • 3. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T, Sava G, Cuman R, Nisi C, Lassiani L.
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [Abstract] [Full Text] [Related]

  • 4. Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicin.
    Giuliani F, Casazza AM, Di Marco A, Savi G.
    Cancer Treat Rep; 1981 Jun; 65(3-4):267-76. PubMed ID: 6263470
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of experimental lung metastases by cultured B16 melanoma cells treated with (+/-)-1,2-bis(3,5-dioxopiperazin-1-y)propane (ICRF-159).
    Lazo JS, Ingber DE, Sartorelli AC.
    Cancer Res; 1978 Aug; 38(8):2263-70. PubMed ID: 667822
    [No Abstract] [Full Text] [Related]

  • 6. Different metastatic potential of in vitro and in vivo lines selected from Lewis lung carcinoma: correlation with response to different bleomycin schedulings.
    Sacchi A, Calabresi F, Greco C, Zupi G.
    Invasion Metastasis; 1981 Aug; 1(4):227-38. PubMed ID: 6203864
    [Abstract] [Full Text] [Related]

  • 7. Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma.
    Grill V, Mallardi F, Zorzet S, Perissin L, Giraldi T.
    Clin Exp Metastasis; 1987 Sep; 5(3):233-44. PubMed ID: 3652553
    [Abstract] [Full Text] [Related]

  • 8. Metastatic heterogeneity of cells from Lewis lung carcinoma.
    van Lamsweerde AL, Henry N, Vaes G.
    Cancer Res; 1983 Nov; 43(11):5314-20. PubMed ID: 6616467
    [Abstract] [Full Text] [Related]

  • 9. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
    Sava G, Giraldi T, Zupi G, Sacchi A.
    Invasion Metastasis; 1984 Nov; 4(3):171-8. PubMed ID: 6480289
    [Abstract] [Full Text] [Related]

  • 10. Characterization of spontaneous metastases from autochthonous 3-methylcholanthrene-induced tumors.
    Bottazzi B, Mantovani A, Taraboletti G, Giavazzi R.
    Invasion Metastasis; 1986 Nov; 6(1):44-57. PubMed ID: 3941028
    [Abstract] [Full Text] [Related]

  • 11. Phase III study of ICRF-159 versus 5-FU in the treatment of advanced metastatic colorectal carcinoma.
    Paul AR, Catalano RB, Engstrom PF.
    Cancer Treat Rep; 1980 Nov; 64(10-11):1047-9. PubMed ID: 7006805
    [Abstract] [Full Text] [Related]

  • 12. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
    Gorelik E, Segal S, Feldman M.
    J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
    [Abstract] [Full Text] [Related]

  • 13. Relationship between primary tumor volume and lung metastasis in Lewis lung carcinoma (II). Tumor bed effect.
    Ohizumi Y, Maezawa H, Mori T.
    Tokai J Exp Clin Med; 1987 Nov; 12(4):237-42. PubMed ID: 3503393
    [Abstract] [Full Text] [Related]

  • 14. Treatment with monoclonal antibody to a Lewis lung carcinoma-associated antigen: different effects on primary tumor and its metastases.
    Sacchi A, Kennel SJ, Apollonj C, Natali PG.
    Cancer Treat Rep; 1985 Sep; 69(9):985-91. PubMed ID: 4028039
    [Abstract] [Full Text] [Related]

  • 15. Relationship between primary tumor volume and lung metastasis in Lewis lung carcinoma (1). Assay for time course of development of metastasis.
    Ohizumi Y, Maezawa H, Mori T.
    Tokai J Exp Clin Med; 1987 Nov; 12(4):229-35. PubMed ID: 3503392
    [Abstract] [Full Text] [Related]

  • 16. Effects of ticlopidine on metastasis production in mice bearing Lewis lung carcinoma.
    Fabra A, de Castellarnau C, Carretero F, Martínez E, Sancho MJ, Rutllant ML.
    Invasion Metastasis; 1987 Nov; 7(1):53-60. PubMed ID: 3583621
    [Abstract] [Full Text] [Related]

  • 17. Inheritance of cellular resistance to the antitumor agent ICRF 159 in somatic cell hybrids.
    Edgar DH, Creighton AM.
    J Natl Cancer Inst; 1982 Jun; 68(6):977-80. PubMed ID: 6953277
    [Abstract] [Full Text] [Related]

  • 18. [Effects of bimolane on size, metastases and cyclic AMP levels of Lewis lung carcinoma].
    Huang KW, Fu NW, Ren YF.
    Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):69-71. PubMed ID: 6326466
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
    Talmadge JE, Fidler IJ.
    J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200
    [Abstract] [Full Text] [Related]

  • 20. Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells.
    Nakanishi H, Oguri K, Takenaga K, Hosoda S, Okayama M.
    Lab Invest; 1994 Mar; 70(3):324-32. PubMed ID: 7511714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.